Iconovo AB

Iconovo AB ICONOVO develops novel and innovative inhalation devices. The proprietary devices are available for testing and licensing.

ICONOVO AB is developing propitiatory inhalation devices for licensing. We have long experience and track record in the development of dry powder inhalers and offer a comprehensive range of devices to our clients. Our selection of device concepts for dry powder inhalation include a reservoir inhaler, a pre-metered inhaler, a capsule based inhaler and a single dose disposable inhaler. Together with

our partners we can, also provide a formulation, performance testing, documentation and a complete supply-chain. Instagram: iconovoab
Twitter:

18/10/2018

Our Facebook-page is not active. Please visit us on Linkedin or on our webpage iconovo.se

ICONOVO INVESTS IN FORMULATION DEVELOPMENT CAPABILITYIconovo has raised 2.3 million EUR to expand the in-house developme...
21/06/2017

ICONOVO INVESTS IN FORMULATION DEVELOPMENT CAPABILITY

Iconovo has raised 2.3 million EUR to expand the in-house development capacity. We will now be able to offer a comprehensive product development including device, formulation and analytical testing.

11/05/2017

Adress

Scheelevägen 2
Lund
22381

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när Iconovo AB postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Affären

Skicka ett meddelande till Iconovo AB:

Dela



Du kanske också gillar